Prostate Cancer Biomarkers and PVSA Research Presented
Fellow Health showcased innovative research, emphasizing mail-in semen testing to enhance prostate cancer diagnostics and PVSA care.
Category: Prostate
Prostate
Latest
Prostate
Latest
How Prostate Cancer Screening Advancements Are Reducing Overtreatment
A new prostate cancer screening method could help better predict which patients need to undergo a biopsy, reducing unnecessary procedures.
Prostate
Latest
New Urine Test Detects High-Grade Prostate Cancer
The new urine-based test aims to differentiate between slow-growing and aggressive forms of prostate cancer.
AI Algorithm Promises to Improve Workflows at Ohio Cancer Center
Pathologists at OSUCCC-James have been evaluating an AI algorithm for the past year. The results are extremely promising.
Read More
Rectal Examinations Do Not Improve Prostate Cancer Screening Effectiveness
A new study has found that rectal examination has no advantages over the PSA blood test for detecting prostate cancer.
Read More
Blood Test Distinguishes Neuroendocrine Subtype of Advanced Prostate Cancer
Researchers have developed a blood test that can reliably detect NEPC and differentiate it from CRPC-adenocarcinoma.
Read More
ArteraAI Gets Medicare Payment Rate for Prostate Cancer Test
ArteraAI says the CMS decided on the payment rate for the ArteraAI Prostate Test, a clinical diagnostic laboratory test for prostate cancer.
Read More
$3M Grant to Develop AI to Detect Aggressive Prostate Cancer
UCLA Researchers have received a five-year, $3 million grant to develop AI that can detect and predict aggressive prostate cancer.
Read More
Biomarker HSD3B1 Identified as Reason for Therapeutic Resistance
Men with biomarker HSD3B1 may exhibit resistance to combined radiation and hormone therapy for prostate cancer.Â
Read More
Black Men are More Likely to Have Prostate Cancer than White Men
Black men are more likely to develop prostate cancer than white men and more likely to have advanced disease and to die than white men.Â
Read More
ArteraAI Validates Prognostic Model in Advanced Prostate Cancer
ArteraAI will present data demonstrating the successful validation of its prognostic model in advanced prostate cancer.
Read More
New Algorithm Predicts Prostate Cancer Recurrence for Radiation Therapy Patients
Researchers developed a patent-pending method and algorithm to predict prostate cancer recurrence in patients treated by radiation therapy.Â
Read More
Precision Medicine Navigators Increase Genomic Testing Rates for Black Patients with Prostate Cancer
Black patients seen by a precision medicine navigator were substantially more likely to receive genomic testing than those who were not.
Read More
Detecting Metastatic Prostate Cancer Risk in Black Men
To explore why prostate cancer disproportionately harms Black men, researchers looked to another disorder, diabetes, which alters metabolism.
Read More
Researcher Leads Development of Urine Test for Prostate Cancer Detection
Biomarkers of significant prostate cancer that are detected in urine or blood tests are desperately needed to help reduce prostate biopsies.
Read More
How Veracyte’s Prostate Genomic Classifier Guides Cancer Treatment
A new study demonstrated Decipher Prostate Genomic Classifier’s ability to guide personalized treatment for men with prostate cancer.Â
Read More
Quest Launches Prostate Cancer Test to Improve Diagnosis and Grading
Quest launched a prostate cancer biomarker test through its pathology business, AmeriPath, in collaboration with Envision Sciences.Â
Read More
AI Model IDs Patients to Best Benefit from ADT for Prostate Cancer Treatment
The AI-based predictive model was able to identify patients with a predominantly intermediate risk for prostate cancer likely to benefit from short-term ADT.
Read More